Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Agency: Food and Drug Administration
- 93.103 -- Food and Drug Administration Research
Forecasted opportunityLast Updated: May 13, 2026
Important dates
- Forecasted post date: Not specified
- Forecasted application due date: Not specified
- Forecasted award date: Not specified
- Forecasted project start date: Not specified
- Fiscal Year: 2025
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
$650,000
Award max.
$900,000
- Funding opportunity number:FOR-FD-25-001
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Consumer protection
- Food and nutrition
- Agriculture
- Category Explanation:Not specified
History
- Forecast posted date: August 14, 2024
- Archive date: Not specified
- Version: 1
Summary
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.
Eligibility
Government
- Special district governments
- Public and Indian housing authorities
- State governments
- Federally recognized Native American tribal governments
- City or township governments
- County governments
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
Education
- Public and state institutions of higher education
- Independent school districts
- Private institutions of higher education
Miscellaneous
- Unrestricted
Business
- Small businesses
- For-profit organizations other than small businesses
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: terrin.brown@fda.hhs.gov
terrin.brown@fda.hhs.gov
Link to additional information
No additional information is available
